Pancreaticobiliary Neoplasm — Trials

Pancreaticobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,004 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 828 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03572400	Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer	unknown	Phase 2	71	Do-Youn OhOTHER	1	Apr 19, 2024	clinicaltrials
NCT04298008	AZD6738 Plus Durvalumab in Biliary Tract Cancer	unknown	Phase 2	26	Seoul National University HospitalOTHER	1	Apr 19, 2024	clinicaltrials